Histological alterations in bone marrow in patients with late engraftment after autologous bone marrow transplantation

Bone Marrow Transplantation

Volumn 25, Issue 8, 2000, Pages 837-841

  Annaloro, C ^a   Oriani, A ^a   Pozzoli, E ^a   Lambertenghi Deliliers, D ^b   Bertolli, V G ^a   Della Volpe, A ^a   Soligo, D ^a   Lambertenghi Deliliers, G ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

AML; Autologous BMT; Bone marrow biopsy; Engraftment

Indexed keywords

RETICULIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW; BONE MARROW BIOPSY; CLINICAL ARTICLE; FEMALE; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RELAPSE; VIRUS REACTIVATION;

EID: 0034085092     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702241     Document Type: Article

References (25)

1. Ippoliti C, Przepiorka D, Giralt S et al. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation. Bone Marrow Transplant 1993; 11: 55-59.
2. Crump M, Couture F, Kovacs M et al. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Exp Hematol 1993: 21: 405-410.
3. Khwaja A, Goldstone AH, Linch DC. Delayed neutrophil recovery after BEAM chemotherapy and autologous bone marrow transplantation for lymphoma is not associated with increased mortality from infection. Bone Marrow Transplant 1995; 15: 313-315.
4. Rajantie J, Sale GE, Deeg HJ et al. Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood 1986; 67: 1693-1697.
5. Lazarus HM, Chahine A, Lacerna K et al. Kinetics of erythrogenesis after bone marrow transplantation. Am J Clin Pathol 1992; 97: 574-583.
6. Hirao A, Kawano Y, Takaue Y et al. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system. Exp Hematol 1994; 22: 521-526.
7. Deeg HJ, Beckham C, Huss R et al. Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand. Blood 1994; 83: 2352-2359.
8. Enright H, Haake R, Weisdorf D. A vascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 1990; 89: 733-738.
9. Verdonck LF, de Gast GC, van Heutgen HG et al. Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood 1991; 78: 844-848.
10. Beguin Y, Oris R, Fillet G. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous vs allogeneic transplants. Bone Marrow Transplant 1993; 11: 285-292.
11. Brandwein JM, Nayar R, Baker MA et al. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation. Exp Hematol 1991; 19: 191-195.
12. Haas R, Witt B, Möhle R et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995; 85: 3754-3761.
13. Vey N, Molnar S, Faucher C et al. Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery. Bone Marrow Transplant 1994; 14: 779-782.
14. Vose JM, Bierman PJ, Kessinger A et al. The use of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of delayed engraftment following highdose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. Bone Marrow Transplant 1991; 7: 139-143.
15. Pendry K, Alcorn MJ, Burnett AK. Factors influencing haematological recovery in 53 patients with acute myeloid leukaemia in first remission after autologous bone marrow transplantation. Br J Haematol 1993; 83: 45-52.
16. Tiedemann K, Waters KD, Tauro GP et al. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Blood 1993; 82: 3730-3738.
17. Robertson MJ, Soiffer RJ, Freedman AS et al. Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia. Blood 1992; 79: 2229-2236.
18. Lenarsky C, Weinberg K, Petersen J et al. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission. Bone Marrow Transplant 1990; 6: 425-429.
19. Jackson GH, Clarke AJ, Taylor P et al. Supernatant cell counts from long-term bone marrow cultures correlate with the speed of engraftment following autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 439-444.
20. Straetmans N, Ma DDF, Herman Ph et al. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment. Bone Marrow Transplant 1995; 15: 421-428.
21. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
22. Domenech J, Roingeard F, Binet C. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation. Leuk Lymphoma 1997; 24: 239-256.
23. Rosenthal NS, Farhi DC. Failure to engraft after bone marrow transplantation: bone marrow morphologic findings. Am J Clin Pathol 1994; 102: 821-824.
24. Wilson PA, Ayscue LH, Jones GR, Bentley SA. Bone marrow histiocytic proliferation in association with colony-stimulating factor therapy. Am J Clin Pathol 1993; 99: 311-313.
25. Bierkens JG, Hendry JH, Testa NG. The radiation response and recovery of bone marrow stroma with particular reference to long-term bone marrow cultures. Eur J Haematol 1989; 43: 95-107.